Free Trial

Kodiak Sciences (KOD) Competitors

Kodiak Sciences logo
$9.92 +0.19 (+1.95%)
Closing price 09/11/2025 04:00 PM Eastern
Extended Trading
$10.05 +0.13 (+1.30%)
As of 09:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KOD vs. IRON, BEAM, CNTA, BLTE, AGIO, HRMY, ANIP, ARQT, DYN, and RXRX

Should you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include Disc Medicine (IRON), Beam Therapeutics (BEAM), Centessa Pharmaceuticals (CNTA), Belite Bio (BLTE), Agios Pharmaceuticals (AGIO), Harmony Biosciences (HRMY), ANI Pharmaceuticals (ANIP), Arcutis Biotherapeutics (ARQT), Dyne Therapeutics (DYN), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "pharmaceutical products" industry.

Kodiak Sciences vs. Its Competitors

Disc Medicine (NASDAQ:IRON) and Kodiak Sciences (NASDAQ:KOD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

In the previous week, Disc Medicine had 5 more articles in the media than Kodiak Sciences. MarketBeat recorded 11 mentions for Disc Medicine and 6 mentions for Kodiak Sciences. Disc Medicine's average media sentiment score of 1.71 beat Kodiak Sciences' score of 0.21 indicating that Disc Medicine is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Disc Medicine
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Kodiak Sciences
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

83.7% of Disc Medicine shares are owned by institutional investors. Comparatively, 89.1% of Kodiak Sciences shares are owned by institutional investors. 3.6% of Disc Medicine shares are owned by insiders. Comparatively, 45.9% of Kodiak Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Disc Medicine's return on equity of -26.60% beat Kodiak Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Disc MedicineN/A -26.60% -24.58%
Kodiak Sciences N/A -155.27%-63.29%

Disc Medicine presently has a consensus target price of $98.30, indicating a potential upside of 63.05%. Kodiak Sciences has a consensus target price of $11.75, indicating a potential upside of 18.45%. Given Disc Medicine's stronger consensus rating and higher possible upside, analysts clearly believe Disc Medicine is more favorable than Kodiak Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Disc Medicine
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
3.09
Kodiak Sciences
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Disc Medicine is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Disc MedicineN/AN/A-$109.36M-$4.47-13.49
Kodiak SciencesN/AN/A-$176.21M-$3.80-2.61

Disc Medicine has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Kodiak Sciences has a beta of 2.45, meaning that its stock price is 145% more volatile than the S&P 500.

Summary

Disc Medicine beats Kodiak Sciences on 9 of the 14 factors compared between the two stocks.

Get Kodiak Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KOD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOD vs. The Competition

MetricKodiak SciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$513.69M$3.15B$5.78B$10.07B
Dividend YieldN/A2.32%5.69%4.62%
P/E Ratio-2.6121.6075.0426.20
Price / SalesN/A297.80469.7391.86
Price / CashN/A45.3337.0859.91
Price / Book3.479.7112.236.28
Net Income-$176.21M-$53.33M$3.29B$270.85M
7 Day Performance-5.70%1.04%1.53%3.58%
1 Month Performance16.43%9.93%7.86%6.67%
1 Year Performance316.81%13.80%63.05%27.74%

Kodiak Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOD
Kodiak Sciences
3.63 of 5 stars
$9.92
+2.0%
$11.75
+18.4%
+301.6%$513.69MN/A-2.6190
IRON
Disc Medicine
3.2931 of 5 stars
$61.91
+1.9%
$98.30
+58.8%
+24.3%$2.11BN/A-13.8530Positive News
High Trading Volume
BEAM
Beam Therapeutics
3.0504 of 5 stars
$19.94
-4.5%
$48.45
+143.0%
-10.7%$2.11B$63.52M-4.43510
CNTA
Centessa Pharmaceuticals
3.2442 of 5 stars
$18.03
+14.6%
$31.45
+74.5%
+64.9%$2.11B$6.85M-10.07200Insider Trade
High Trading Volume
BLTE
Belite Bio
2.6717 of 5 stars
$67.51
+2.7%
$96.67
+43.2%
+40.8%$2.09BN/A-43.5510Positive News
AGIO
Agios Pharmaceuticals
4.3547 of 5 stars
$36.41
+1.1%
$56.00
+53.8%
-17.6%$2.09B$40.88M3.31390Insider Trade
HRMY
Harmony Biosciences
4.5717 of 5 stars
$35.83
-0.4%
$51.00
+42.3%
-10.4%$2.07B$714.73M11.56200Positive News
High Trading Volume
ANIP
ANI Pharmaceuticals
4.0661 of 5 stars
$95.20
-0.2%
$88.25
-7.3%
+81.8%$2.07B$747.40M-123.63600Positive News
ARQT
Arcutis Biotherapeutics
2.1074 of 5 stars
$17.33
+1.0%
$19.80
+14.3%
+68.2%$2.06B$196.54M-23.11150Insider Trade
DYN
Dyne Therapeutics
3.8139 of 5 stars
$13.30
-6.5%
$34.07
+156.1%
-59.6%$2.02BN/A-3.45100Positive News
RXRX
Recursion Pharmaceuticals
2.1821 of 5 stars
$4.62
+0.2%
$7.25
+56.9%
-24.8%$2.00B$58.84M-2.60400News Coverage
Analyst Forecast
Options Volume

Related Companies and Tools


This page (NASDAQ:KOD) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners